Lumina AI is proud to announce that Ben Martin and Sam Martin, co-inventors of RCL with Dr. Morten Middelfart, are rejoining the company as AI Research Scientists to support its next phase of growth.

Year Results and Business Update Positive Phase I data with TG4050 in operable Head and Neck Squamous Cell Carcinoma (HNSCC) 100% disease-free survival after 2 years of follow-up — data presented in a ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

Dr. Allison Winter secured a VeloSano grant after five years of rejected proposals for central nervous system lymphoma ...

The CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium has published new consensus ...

Sacubitril/valsartan shows evidence of benefit in the first randomized trial evaluating a drug treatment for patients with ...

Congress showed that vaccines against influenza and respiratory syncytial virus protect against adverse cardiovascular and ...

The race between AI-powered attacks and AI-powered defenses will define cybersecurity's next decade. Winners will recognize ...

Results of a new study support using semaglutide and tirzepatide to reduce risk in patients with cardiometabolic heart failure with preserved ejection fraction.The study investigated the effectiveness ...

How do cells know what they should become as the body develops? Biological development depends crucially on spatial patterns: ...

Learn from the latest clinical practice guidelines on PTSD; discover which treatments are the gold standard and how they can ...

The sort of violence that took the life of a Ukrainian refugee, Iryna Zarutska, on a light-rail train in Charlotte, North ...